Intelligent Living Application Group Inc. Announces Pricing of $600,000 Public Offering of Ordinary Shares

Intelligent Living Application Group Inc. Announces Pricing of $600,000 Public Offering of Ordinary Shares

HONG KONG, Feb. 26, 2025 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ: ILAG) ("Intelligent Living" or the "Company"), a premium lockset manufacturer in Hong Kong, today announced the pricing of its "best efforts" public offering...

Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

BEIJING, Feb. 26, 2025 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider in China, today announced its unaudited financial results for...

ASG Announces the Completion of pre-IND meeting with FDA for Lead Drug Beta1, Receiving Encouraging Feedback

ASG Announces the Completion of pre-IND meeting with FDA for Lead Drug Beta1, Receiving Encouraging Feedback

TAIPEI, Feb. 26, 2025 /PRNewswire/ -- Asia Scientific Global (ASG), a company specializing in the research and development of novel inhaled novel drugs, announced the completion of pre-IND meeting with the U.S. Food and Drug Administration (FDA) for...

FranklinWH Announces aPower S with Direct Solar Integration and Begins US Domestic Manufacturing

FranklinWH Announces aPower S with Direct Solar Integration and Begins US Domestic Manufacturing

aPower S offers a simple and flexible pairing for solar and storage, while FranklinWH begins manufacturing in California SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- FranklinWH Energy Storage Inc. (FranklinWH) today announced the release of the...

Axiom Announces AI-Enabled Contracting Solution, Proven to Improve Efficiency of Contract-Related Legal Tasks by up to 60%

Axiom Announces AI-Enabled Contracting Solution, Proven to Improve Efficiency of Contract-Related Legal Tasks by up to 60%

Field tested by Axiom lawyers in actual client engagements, Axiom pairs top-rated legal talent with DraftPilot AI to speed contract reviews, analysis, and redlining, and enhance contract review quality NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Today...

China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results

China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results

SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery...

Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results

Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25, 2025 GUANGZHOU, China, Feb. 25, 2025 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its...

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from the ongoing...

Ericsson announces changes to the Executive Team and to the Market Area structure

Ericsson announces changes to the Executive Team and to the Market Area structure

Per Narvinger, currently Head of Business Area Cloud Software and Services, is appointed Executive Vice President and new Head of Business Area Networks as of March 15, 2025 Jenny Lindqvist, currently Head of Market Area Europe & Latin America,...

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint of a reduction in proteinuria in the diabetic kidney disease (DKD)...

  • 1
  • ...
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • ...
  • 85
  • menu
    menu